Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2007-01-23
2007-01-23
Allen, Marianne P. (Department: 1647)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C530S399000, C530S350000
Reexamination Certificate
active
09933309
ABSTRACT:
Human growth hormone therapy and thymic regeneration are effected by the generally simultaneous administration of one of human growth hormone, its analogs, precursors, metabolites, releasers or mixtures thereof in combination with one of DHEA, its precursors, releasers, analogs, metabolites or combinations thereof.
REFERENCES:
“Insulin Resistance, A Multifaceted Syndrome Responsible for NIDDM, Obesity, Hypertension, Dyslipidemia, and Atherosclerotic Cardiovascular Disease,”Diabetes Care, vol. 14, No. 3, Mar. 1991, DeFronzo et al., pp. 173-194.
“Effects of One Year of Supplentation with Zinc and Other Micronutrients on Cellular Immunity in the Elderly,”Journal of the American College of Nutrition, vol. 9, No. 3, pp. 214-225 (1990), Bogden et al.
“Dietary Modulation of the Immune Response in the Aged,”Age, vol. 14, pp. 108-115, 1991, Meydani.
“Effects of Short Term Administration of Recombinant Human Growth Hormone to Elderly People, Journal of Clinical Endocrinology and Metabolism,”vol. 70, No. 2, pp. 519-527, Marcus et al., 1990.
“Exogenous Growth Hormone Treatment Alters Body Compositions and Increases Natural Killer Cell Activity in Women with Impaired Endogenous Growth Hormone Section,”Metabolism, vol. 36, No. 12 (Dec.), 1987, pp. 1115-1117 Crist et al.
“Growth Hormane treatment stimulates thymulin production in aged dogs”, Clin. exp. Immunol., (1987) 68, pp. 580-587, Goff et al.
“GH3pituitary adenoma cells can reverse thymic aging in rats,” Proc. Natl. Acad. Sci. USA, vol. 83, pp. 5663-5667, Aug. 1986, Kelley et al.
“Effects of Long-Term, Low-Dose Growth Hormone Therapy on Immune Function and Life Expectancy of Mice, Mechanisms of Ageing and Development,” 57 (1991) pp. 87-100, Khansari et al.
“A Nonpeptidyl Growth Hormone Secretagogue,” Science, vol. 260, Jun. 11, 1993, pp. 1640-1643, Smith et al.
“Effects of Human Growth Hormone in Men Over 60 Years Old,” Journal of Medicine, vol. 323, Jul. 5, 1990, No. 1, pp. 1-6, Rudman et al.
“Effects of Human Growth Hormone on Body Composition in Elderly Men,” Horm Res. 1991;36(suppl 1), pp. 73-81, Rudman et al.
“Evaluation of intrathymic islet transplantation in the prediabetic period, ”Surgery Aug. 1992, pp. 319-326, Brayman et al.
“Lack of Effect of Dehydroepiandrosterone in Obese Men”, International Journal of Obesity (1990), 14, pp. 457-463, Usiskin et al.
“Dehydroepiandrosterone: the “missing link” between hyperinsulinemia and atheroclerosis?,”The FASEB Journal, vol. 6, Sep. 1992, pp. 3073-3075, Nestler et al.
“The Effects of Oral Dehydroepiandrosterone on Endocrine-Metabolic Parameters in Postmenopausal Women,”Journal of Clinical Endocrinology and Metabolism, vol. 71, No. 3, pp. 696-704, Mortola et al.
“Bimodal Correlation between the Circulating Insulin Level and the Production Rate of Dehydroepiandrosterone: Positive Correlation in Controls and Negative Correlation in the Polycystic Ovary Syndrome with Acanthosis Nigricans,” Journal of Clinical Endocrinology and Metabolism, vol. 70, 4, 1990, pp. 1075-1081, Farah et al.
“Dietary Chromium Supplementation with or without Somatotropin Treatment Alters Serum Hormones and Metabolites in Growing Pigs without Affecting Growth Performance,” 1993 American Institute of Nutrition, pp. 1504-1512, Evock-Clover et al.
“Chromium Picolinate Increases Longevity,” Evans et al., AGE, vol. 15, p. 134, Abstract 51, 1992.
“Hormone may restore muscle in elderly,” Fackelmann, Science News, Jul. 14, 1990.
“New Transplant Method Evades Immune Attack,” Naji, Science vol. 249, p. 1248, 1990.
“Induction of Donor-Specific Unresponsiveness by Intrathymic Islet Transplantation,” Posselt et al., Science vol. 249, pp. 1293-1295, 1990.
“Promotion of rat cardiac allograft survival by intrathymic inoculation of donor splenocytes,” Odorico et al., Transplantation vol. 55, No. 5, pp. 1104-1107, May 1993.
“Kidney graft survival in rats without immunosuppressants after intrathymic glomerular transplantation,” Remuzzi et al., Lancet 337, pp. 750-752, 1991.
“Prevention of Autoimmune Diabetes in the BB Rat by Intrathymic Islet Transplantation at Birth,” Posselt et al., Science vol. 256, pp. 1321-1324, May 1992.
“Thymus-Mediated Immune Tolerance to Renal Allograft is Donor but Not Tissue Specific,”Perico et al., J.Am.Sco. Nephrol vol. 2, No. 6, pp. 1063-1071, 1991.
“Regeneration of the thymus in old male rats treated with a stable analogue of LHRH,” Greenstein et al., J.Endocrinol 112, pp. 345-350, 1987.
“Thyroid Function Modulates Thymic Endocrine Activity,” Fabris et al., J.Clin. Endocrinal. Metab. vol. 62, No. 3, pp. 474-478, 1986.
“Zinc, Immunity, and Aging,” Fabris et al., (A.L. Goldstein, Ed.), Plenum Press, New York, pp. 271-281, 1990.
“Coenzyme Q, the Immune System and Aging,” Buznakov, Biomedical and Clinical Aspects of Coenzyme Q, vol. 3 (K. Folkers and Y. Yamamura, eds.), Elsevier/North Holland Biomedical Press, New York, pp. 311-323, 1981.
“Dehydroepiandrosterone Reduces Serum Low Density Lipoprotein Levels and Body Fat but Does not Alter Insulin Sensitivity in Norman Men,” Nestler et al., J.Clin. Endrocrinol. Metab. vol. 66, No. 1, pp. 57-61, 1988.
“A Prospective Study of Dehydroepiandrosterone Sulfate, Mortality, and Cardiovascular Disease,” Barrett-Conner et al., New England J. Med. vol. 315, No. 24, pp. 1519-1524, 1986.
“Role of Adrenal and Gonadal Androgens in Insulin Action and Metabolism,” Kitabchi et al., Folia Endocrinol. 67, pp. 203-213, 1991.
“The influence of preoperative drug treatment on the extent of hyperplasia of the thymus in primary thyrotoxicosis,” Simpson et al., Clin. exp. Immunol. 22, pp. 249-255, 1975.
“Short-Term and Long-Term Possibilities for Interventive Gerontology,” Fahy, The Mount Sinai Journal of Medicine, vol. 58, No. 4, pp. 328-340, Sep. 1991.
“Reduction of Atherosclerosis by Administration of Dehydroepiandrosterone,” Gordon et al., J.Clin.Invest., The American Society for Clinical Invest., Inc., vol. 82, pp. 712-720, Aug. 1988.
“Intrathymic Islet Transplantation in the Spontaneously Diabetic BB Rat,” Ann. Surg. vol. 214, No. 4, 1991, Posselt et al., pp. 363-373.
“Immunological Tolerance to a Defined Myelin Basic Protein Antigen Administered Intrathymically,” The Journal of Immunology, vol. 153, 1994, Goss et al., pp. 3890-3898.
“Intrathymic Implants of Genetically Modified Fibroblasts,” The FASEB Journal, vol. 6, Jul. 1992, Behara et al., pp. 2853-2858.
“Prevention of Diabetes and Insulitis by Neonatal Intrathymic Islet Administration in NOD Mice,” Journal of Autoimmunity Vol. 7, 1994, Charlton et al., pp. 549-560.
“Effect of Bovine Growth Hormone Administration on the Pattern of Thymic Involution in Mice,” Thymus, vol. 23, 1994, Bar-Dayan et al., pp. 95-101.
“A Murine Model for Regeneration of the Senescent Thymus Using Growth Hormone Therapy,” AGING: Immunology and Infection Disease, vol. 3, No. 1, 1991, McCormick et al., pp. 19-26.
“Protection From Glucocorticoid Induced Thymic Involution By Dehydroepiandrosterone,” Pediatric Res, vol. 25 (4 pt 2), 1989, May et al., p 89A.
“The Role of the Thymus in Multiple Sclerosis,” The Italian Journal of Neurological Sciences, vol. 10, 1989, D'Andrea et al., pp. 43-48.
Judd, MD, R. and Bueso-Ramos, MD, C., “Combined True Thymic Hyperplasia and Lymphoid Hyperplasia In Graves' Disease,”Pediatric Pathology, vol. 10, pp. 829-836, 1990.
Allen Marianne P.
DeBerry Regina M.
Price Heneveld Cooper DeWitt & Litton LLP
LandOfFree
Method for the prevention of transplant rejection does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for the prevention of transplant rejection, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for the prevention of transplant rejection will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3724563